Comment on ‘The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study'

por Paradiso, A V, Digennaro, M, Sambiasi, D
Publicado 2016

Hereditary and non-hereditary branches of family eligible for BRCA test: cancers in other sites

por Digennaro, M., Sambiasi, D., Tommasi, S., Pilato, B., Diotaiuti, S., Kardhashi, A., Trojano, G., Tufaro, A., Paradiso, A. V.
Publicado 2017

Expression of base excision repair key factors and miR17 in familial and sporadic breast cancer

por De Summa, S, Pinto, R, Pilato, B, Sambiasi, D, Porcelli, L, Guida, G, Mattioli, E, Paradiso, A, Merla, G, Micale, L, De Nittis, P, Tommasi, S
Publicado 2014

Phase I/II study of gemcitabine plus mitoxantrone as salvage chemotherapy in metastatic breast cancer

por Lorusso, V, Crucitta, E, Silvestris, N, Catino, A, Caporusso, L, Mazzei, A, Guida, M, Latorre, A, Sambiasi, D, D'Amico, C, Schittulli, F, Calabrese, P, De Lena, M
Publicado 2003